SCHEMBL27180899

SCHEMBL27180899

Cc1nc2ccc(NC(=O)c3cccc(S(=O)(=O)N4CCc5ccccc54)c3)cc2s1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.69
KDM4E B2RXH2 4/20 0.69
ALDH1A1 P00352 9/20 0.69
SMN1; SMN2 Q16637 6/20 0.69
HTT P42858 5/20 0.69
KMT2A Q03164 5/20 0.69
MEN1 O00255 4/20 0.69
LMNA P02545 4/20 0.69
GAA P10253 2/20 0.67
CASP3 P42574 1/20 0.67
SENP8 Q96LD8 1/20 0.67
SENP7 Q9BQF6 1/20 0.67
SENP6 Q9GZR1 1/20 0.67
NPSR1 Q6W5P4 1/20 0.67
HPGD P15428 2/20 0.65
RECQL P46063 1/20 0.65
TP53 P04637 1/20 0.65
L3MBTL1 Q9Y468 1/20 0.65
POLB P06746 2/20 0.62
MAPK1 P28482 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30926490 1.00 MAPT (0.69) MAPTKDM4EALDH1A1SMN1; SMN2HTT
SCHEMBL27180019 0.86 MAPT (0.73) MAPTKDM4EALDH1A1SMN1; SMN2HTT
SCHEMBL30926969 0.86 MAPT (0.73) MAPTKDM4EALDH1A1SMN1; SMN2HTT
SCHEMBL663583 0.85 MAPT (0.82) MAPTKDM4EALDH1A1SMN1; SMN2HTT
SCHEMBL27180123 0.83 MAPT (0.75) MAPTKDM4EALDH1A1SMN1; SMN2HTT
SCHEMBL30926716 0.83 MAPT (0.75) MAPTKDM4EALDH1A1SMN1; SMN2HTT
SCHEMBL27180848 0.83 SMN1; SMN2 (0.81) MAPTALDH1A1SMN1; SMN2HTTKMT2A
SCHEMBL27180377 0.82 CASP3 (0.80) MAPTALDH1A1SMN1; SMN2HTTKMT2A
SCHEMBL30926868 0.81 SMN1; SMN2 (0.65) MAPTKDM4EALDH1A1SMN1; SMN2HTT
SCHEMBL27179851 0.81 SMN1; SMN2 (0.65) MAPTKDM4EALDH1A1SMN1; SMN2HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4580404-A2 SULFONAMIDE APYRASE INHIBITORS Texas Crop Science, Inc. (US) 2025-07-09 EP claimed
US-20240099300-A1 SULFONAMIDE APYRASE INHIBITORS TEXAS CROP SCIENCE, INC. 2024-03-28 US claimed
WO-2024050041-A2 SULFONAMIDE APYRASE INHIBITORS TEXAS CROP SCIENCE (US) 2024-03-07 WO claimed
US-20240099300-A1 SULFONAMIDE APYRASE INHIBITORS TEXAS CROP SCIENCE, INC. 2024-03-28 US disclosed
WO-2024050041-A2 SULFONAMIDE APYRASE INHIBITORS TEXAS CROP SCIENCE (US) 2024-03-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240099300-A1 SULFONAMIDE APYRASE INHIBITORS APEH, ARSA, DNPEP MAPT 4236/4885KDM4E 1929/4885ALDH1A1 1085/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.